These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36008726)

  • 1. Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS).
    Kesterson K; Schofield J; Blitshteyn S
    J Neurol; 2023 Jan; 270(1):233-239. PubMed ID: 36008726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gluten-free diet in postural orthostatic tachycardia syndrome (POTS).
    Zha K; Brook J; McLaughlin A; Blitshteyn S
    Chronic Illn; 2023 Jun; 19(2):409-417. PubMed ID: 35098721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of chronic postural tachycardia syndrome with positive anti-ganglionic acetylcholine receptor (gAChR) antibody].
    Goto Y; Sunami Y; Sugaya K; Nakane S; Takahashi K
    Rinsho Shinkeigaku; 2021 Aug; 61(8):547-551. PubMed ID: 34275953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Biopsy and Quantitative Sudomotor Axon Reflex Testing in Patients With Postural Orthostatic Tachycardia Syndrome.
    Zhang R; Mayuga K; Shields R; Cantrell C; Wilson R
    Cureus; 2022 Nov; 14(11):e31021. PubMed ID: 36349067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postural orthostatic tachycardia syndrome as a sequela of COVID-19.
    Ormiston CK; Świątkiewicz I; Taub PR
    Heart Rhythm; 2022 Nov; 19(11):1880-1889. PubMed ID: 35853576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of autonomic symptom burden in Postural tachycardia syndrome (POTS).
    Rea NA; Campbell CL; Cortez MM
    J Neurol Sci; 2017 Jun; 377():35-41. PubMed ID: 28477704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND).
    Vernino S; Hopkins S; Bryarly M; Hernandez RS; Salter A
    Clin Auton Res; 2024 Feb; 34(1):153-163. PubMed ID: 38311655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postural Orthostatic Tachycardia Syndrome (POTS): An Update for Clinical Practice.
    Sebastian SA; Co EL; Panthangi V; Jain E; Ishak A; Shah Y; Vasavada A; Padda I
    Curr Probl Cardiol; 2022 Dec; 47(12):101384. PubMed ID: 36055438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients.
    Blitshteyn S; Whitelaw S
    Immunol Res; 2021 Apr; 69(2):205-211. PubMed ID: 33786700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.
    Benarroch EE
    Mayo Clin Proc; 2012 Dec; 87(12):1214-25. PubMed ID: 23122672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distal sudomotor findings in postural tachycardia syndrome.
    Peltier AC; Garland E; Raj SR; Sato K; Black B; Song Y; Wang L; Biaggioni I; Diedrich A; Robertson D
    Clin Auton Res; 2010 Apr; 20(2):93-9. PubMed ID: 20035362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time Course of Autonomic Symptoms in Postural Orthostatic Tachycardia Syndrome (POTS) Patients: Two-Year Follow-Up Results.
    Dipaola F; Barberi C; Castelnuovo E; Minonzio M; Fornerone R; Shiffer D; Cairo B; Zamuner AR; Barbic F; Furlan R
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?
    Blitshteyn S
    J Neurol; 2022 Feb; 269(2):725-732. PubMed ID: 33677650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.
    Kanjwal K; Karabin B; Kanjwal Y; Grubb BP
    Int J Med Sci; 2010 Mar; 7(2):62-7. PubMed ID: 20309394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.
    Zadourian A; Doherty TA; Swiatkiewicz I; Taub PR
    Drugs; 2018 Jul; 78(10):983-994. PubMed ID: 29943373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management.
    Fedorowski A
    J Intern Med; 2019 Apr; 285(4):352-366. PubMed ID: 30372565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies.
    Knoop I; Picariello F; Jenkinson E; Gall N; Chisari C; Moss-Morris R
    Auton Neurosci; 2023 Jan; 244():103052. PubMed ID: 36525900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
    Mar PL; Raj SR
    Annu Rev Med; 2020 Jan; 71():235-248. PubMed ID: 31412221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance.
    Raj SR; Guzman JC; Harvey P; Richer L; Schondorf R; Seifer C; Thibodeau-Jarry N; Sheldon RS
    Can J Cardiol; 2020 Mar; 36(3):357-372. PubMed ID: 32145864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
    Reynolds GK; Lewis DP; Richardson AM; Lidbury BA
    J Intern Med; 2014 Apr; 275(4):409-17. PubMed ID: 24206536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.